Document is current
Any future updates will be listed below
-
Authors
Ransmayr, Gerhard https://orcid.org/0000-0001-9982-1420
Eicher, Edith
Mraczansky, Jürgen
Braoudaki, Eirini
Defrancesco, Michaela
Struhal, Walter
Bancher, Christian
Dal-Bianco, Peter
Marksteiner, Josef
Schmidt, Reinhold
Stögmann, Elisabeth
-
Funding
Funding for this research was provided by:
Johannes Kepler University Linz
- License Information
-
More Information
Article History
Received: 12 June 2025
Accepted: 13 August 2025
First Online: 5 September 2025
Conflict of interest
: G. Ransmayr, E. Eicher, J. Mraczansky, E. Braoudaki, M. Defrancesco, W. Struhal, C. Bancher, P. Dal-Bianco, J. Marksteiner, R. Schmidt and E. Stögmann are members of the managing board of the Austrian Alzheimer Society (ÖAG) and received travel and accommodation expense support from the ÖAG. G. Ransmayr received honoraria for consultations from AbbVie GmbH, Eisai GmbH, Roche Austria GmbH. E. Braoudaki received an honorarium from the Austria Alzheimer Society for designing, programming and maintaining the survey. E. Eicher: no declarations and disclosures. J. Mraczansky: no declarations and disclosures. M. Defrancesco: no further declarations and disclosures. W. Struhal received third party funds from the K. Landsteiner Privatuniversität für Gesundheitswissenschaften, Österreichische Alzheimer Gesellschaft, Donau-Universität Krems, ÖGN, Manz-Rechtsverlag and royalties from Springer, Elsevier, Oxford University Press, Manz. C. Bancher received speakers and consultation honoraria as well as congress support from Schwabe Austria GmbH, Eisai GmbH, Eli Lilly GmbH, Novartis Pharma GmbH, Roche-Austria GmbH P. Dal-Bianco: no further declarations and disclosures. J. Marksteiner: no further declarations and disclosures, R. Schmidt: no further declarations and disclosures. E. Stögmann’s institution (Medical University of Vienna, Austria) received financial support by research grants for research in AD: Eisai, EU Horizon 2020, Austrian Research Promotion Agency. Elisabeth Stögmann’s institution (Medical University of Vienna, Austria) received financial support for participation in clinical trials from Biogen, Novo Nordisc and Roche Diagnostics. E. Stögmann received honoraria (consultations, lectures, speaker bureaus, educational events, advisory boards) from pharmaceutical companies: Biogen, Roche, Novo Nordisc, Eisai, Novartis, Sanofi and Eli Lilly. E. Stögmann held leadership in scientific societies: Austrian Alzheimer Association.
: All authors gave their informed consent to the manuscript.
